Assembly Biosciences (ASMB)
(Delayed Data from NSDQ)
$24.46 USD
+2.19 (9.83%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $24.43 -0.03 (-0.12%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Assembly Biosciences, Inc. has a market cap of $170.86M, which represents its share price of $22.27 multiplied by its outstanding shares number of 7.67M. As a small-cap company, ASMB's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ASMB 24.46 +2.19(9.83%)
Will ASMB be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ASMB based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ASMB
Assembly Biosciences (ASMB) Reports Q1 Loss, Tops Revenue Estimates
Amphastar Pharmaceuticals (AMPH) Tops Q1 Earnings Estimates
ASMB: What are Zacks experts saying now?
Zacks Private Portfolio Services
Assembly Biosciences (ASMB) Soars 24.0%: Is Further Upside Left in the Stock?
BridgeBio Pharma (BBIO) Reports Q1 Loss, Tops Revenue Estimates
Down -22.6% in 4 Weeks, Here's Why Assembly Biosciences (ASMB) Looks Ripe for a Turnaround
Other News for ASMB
ASMB Crossed Above 20 Day Moving Average on September 20
Is ASMB ready to move higher? Crossed Above 50 Day Moving Average shows up after rallying 8.0%
NR7 appears for ASMB after 0.34% move
Is ASMB consolidating before a move? Calm After Storm shows up after sinking 3.02%
Is ASMB positioned for a breakdown? Fell Below 50 Day Moving Average shows up after slipping 3.02%